CAY10499 (MAGL-IN-5) is a non-selective lipase inhibitor with IC 50 values of 144 nM and 14 nM for monoacylglycerol lipase ( MAGL ) and fatty acid amide hydrolase ( FAAH ), respectively. Additionally, CAY10499 exhibits anti-inflammatory and antiviral activities.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Viral Infection | Products > Disease Areas > Pain | Products > Disease Areas > Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > MAGL | Products > Signaling Pathways > FAAH | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Influenza Virus
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.